In a micrometastatic tumor model, 3.7 MBq of 212Pb-L2 demonstrated an increased survival benefit compared to 37 MBq of 177Lu-PSMA-617 (TI of 1.2 vs. 1.0, respectively). Here, FOLH1 is linked to neoplasm.